7,608.59

+28.52

+0.38%

52,280.85

+510.54

+0.99%

25,517.11

+80.11

+0.31%

2,838.01

+26.16

+0.93%

4.8820

-0.0470

-0.95%

19.04

-0.38

-1.95%

3,973.40

+74.50

+1.91%

76,936.53

-917.46

-1.18%

Crude Oil Dec 26

96.63

-7.49

-7.19%

US Private Equity

10,850.63

-82.20

-0.75%

Paris - Delayed Quote EUR

GenSight Biologics S.A. (SIGHT.PA)

0.0731 -0.0041 (-5.31%)

At close: 5:35:26 PM GMT+1

Loading Chart for SIGHT.PA

Chart Range Bar

Interval:

In partnership with ChartIQ

GenSight Biologics Announces the Closing of its €1.0 Million Fundraising Supported by Existing Shareholders

GenSight Biologics Announces the Closing of its €1.0 Million Fundraising Supported by Existing Shareholders

Gensight Biologics and the 15-20 National Hospital Announce NEJM Publication on GS030 Phase 1/2 Trial Results in Late-Stage Retinitis Pigmentosa

Gensight Biologics and the 15-20 National Hospital Announce NEJM Publication on GS030 Phase 1/2 Trial Results in Late-Stage Retinitis Pigmentosa

GenSight Biologics Announces a Successful €1.0 Million Fundraising Supported by Existing Shareholders

GenSight Biologics Announces a Successful €1.0 Million Fundraising Supported by Existing Shareholders

GenSight Biologics Reports Cash Position as of September 30, 2026

GenSight Biologics Reports Cash Position as of September 30, 2026

GenSight Biologics Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates

GenSight Biologics Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates

GenSight Biologics Provides September 2026 Business Updates

GenSight Biologics Provides September 2026 Business Updates

GenSight Biologics Reports Cash Position as of June 30, 2026, and Provides Business Updates

GenSight Biologics Reports Cash Position as of June 30, 2026, and Provides Business Updates

Mobilize your Website

View Site in Mobile | Classic

Share by: